Ten years after the original discovery of this potent molecule, VEGF still holds great therapeutic promise. But who said that it would be easy? Lee, R.J. et al. VEGF gene delivery to myocardium ...

The ability of tumours to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be ...

Standard-of-care options have long included VEGF-R TKI monotherapy or its combination with mammalian target of rapamycin and now also include the HIF-2α inhibitor, belzutifan. 19 However, patients in ...

Summit Therapeutics is making strides with ivonescimab, but upcoming trial results and financial challenges suggest caution.

There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn ...

Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...